NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Procter & Gamble Hygiene and Health Care Reports Mixed Q4FY26 Results

Procter & Gamble Hygiene and Health Care reported a mixed set of numbers for the March quarter and full financial year FY26, with quarterly performance impacted by softer demand conditions and pressure on sales, while annual earnings remained strong.

For Q4FY26, the company posted revenue from operations of ₹941.32 crore, down around 5% from ₹991.63 crore in the corresponding quarter last year, indicating moderation in consumer demand and weakness in volume growth. Total income during the quarter also declined to ₹953.79 crore from ₹1,010.76 crore a year ago. Despite lower sales, profit before tax rose marginally to ₹218.11 crore from ₹212.66 crore in Q4FY25, supported by cost controls and lower raw material expenses. However, net profit slipped slightly to ₹153.13 crore compared to ₹156.10 crore reported in the year-ago quarter, weighed down by higher tax expenses and increased advertising and employee-related costs.

In terms of operating profitability, the company reported EBITDA of ₹220 crore, while EBITDA margins expanded by 186 basis points YoY. The company's quarterly performance was impacted by softer demand conditions and pressure on sales, which resulted in a decline in revenue and total income.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Full Financial Year FY26 Performance

For the full financial year FY26, the company reported a stronger performance, with revenue from operations rising to ₹4,290.42 crore from ₹3,374.42 crore in the previous year. Total income increased to ₹4,332.89 crore compared to ₹3,411.76 crore in FY25. Profit before tax for the year stood at ₹1,166.63 crore versus ₹862.16 crore a year ago, while net profit surged to ₹856.50 crore from ₹636.59 crore in the previous fiscal, driven by improved operating leverage, a better product mix, and higher profitability across segments.

Leadership Changes

The company also announced key leadership changes approved by its board of directors. Ghanashyam Hegde will cease to be the company secretary and compliance officer effective June 30, 2026, after taking up a regional role within P&G and will be redesignated as a non-executive director from July 1, 2026. Meanwhile, Gaurav Bhartia will step down as Chief Financial Officer on June 30, 2026, due to a change in assignment within the group. The company has appointed Srividya Srinivasan as Executive Director and Chief Financial Officer with effect from July 1, 2026.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Gillette India Reports Strong Numbers

Gillette India, the shaving products manufacturer and a subsidiary of P&G, reported a strong set of numbers, with net profit rising 60.13% to ₹158.68 crore, while revenue from operations increased 12.74% YoY to ₹767.47 crore.

Dividend Announcement

Along with the company's financial results, Procter & Gamble Hygiene and Health Care also announced a final dividend of ₹60 per equity share for FY26. "The Board of Directors has recommended a final dividend of ₹60 per equity share for the financial year ended March 31, 2026, subject to the approval of shareholders at the ensuing 62nd Annual General Meeting. Considering the interim dividend, including the one-time special dividend of ₹195 per share already declared, the total dividend payout for the fiscal year will stand at ₹255 per share, subject to shareholder approval," the company said in its filing.

CompanyRevenue from Operations (₹ crore)Net Profit (₹ crore)
Procter & Gamble Hygiene and Health Care4,290.42 (FY26)856.50 (FY26)
3,374.42 (FY25)636.59 (FY25)
Gillette India767.47 (Q4FY26)158.68 (Q4FY26)
- (Q4FY25)- (Q4FY25)

Investor Takeaway

P&G Hygiene and Health Care reported a mixed set of numbers for Q4FY26, with revenue and net profit impacted by softer demand conditions and pressure on sales.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.